Syncom Healthcare - News

NSE: SYNCOM | BSE: 533157

₹4.20

₹0.05 (1.20%)

As on 28-Jun-2021IST

Market cap

₹16 Cr

Revenue (TTM)

₹5 Cr

P/E Ratio

--

P/B Ratio

-1

Div. Yield

0 %

Annual Reports

Annual Reports

2020

Annual Reports

2019

Annual Reports

2018

Annual Reports

2017

Annual Reports

2016

Annual Reports

2015

Annual Reports

2014

Annual Reports

2013

Annual Reports

2012

Annual Reports

2011

Annual Reports

2010

Annual Reports

2009

Annual Reports

2008

Annual Reports

2007

Announcements

View Announcements

Recent

Important

Announcement under Regulation 30 (LODR)-Public Announcement-Delisting

23-Sep-2021

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

16-Aug-2021

Statement Of Investor Complaints For The Quarter Ended June 2021

16-Aug-2021

Announcement under Regulation 30 (LODR)-Newspaper Publication

16-Aug-2021

Shareholding for the Period Ended June 30 2021

14-Aug-2021

Approved The Statement Of Un-Audited Financial Results Of The Company For The Quarter Ended 30Th June 2021 Along With The Limited Review Report Given By The Statutory Auditors Of The Company

14-Aug-2021

Board Meeting Outcome for Approved The Statement Of Un-Audited Financial Results Of The Company For The Quarter Ended 30Th June 2021 Along With The Limited Review Report Given By The Statutory Auditors Of The Company

14-Aug-2021

Board Meeting Intimation for To Consider And Approve The Un-Audited Standalone Financial Results Of The Company For The First Quarter And Three Months Ended On June 30 2021.

06-Aug-2021

Compliance Certificate For The Period Ended 31St March 2021

09-Jul-2021

Statement Of Investor Complaints For The Quarter Ended 31St March 2021 Pursuant To Regulation 13(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015

08-Jul-2021